1. Home
  2. WVE vs MLKN Comparison

WVE vs MLKN Comparison

Compare WVE & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$16.04

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$18.16

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
MLKN
Founded
2012
1905
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
MLKN
Price
$16.04
$18.16
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$29.44
N/A
AVG Volume (30 Days)
13.6M
858.2K
Earning Date
11-10-2025
12-17-2025
Dividend Yield
N/A
4.28%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$109,230,000.00
$3,748,900,000.00
Revenue This Year
N/A
$5.40
Revenue Next Year
$31.09
$3.96
P/E Ratio
N/A
N/A
Revenue Growth
103.75
4.34
52 Week Low
$5.28
$13.77
52 Week High
$21.73
$25.65

Technical Indicators

Market Signals
Indicator
WVE
MLKN
Relative Strength Index (RSI) 63.98 69.24
Support Level $15.23 $16.53
Resistance Level $17.41 $19.15
Average True Range (ATR) 1.83 0.63
MACD 0.22 0.31
Stochastic Oscillator 61.52 72.88

Price Performance

Historical Comparison
WVE
MLKN

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

Share on Social Networks: